{"count":10,"index":{"built_at":"2026-07-28T00:36:02.449327+00:00","public_records":55311,"revision":"6dbdea8e0086e1aca50ae08c"},"query":{"area":null,"kind":null,"lang":null,"limit":10,"match_mode":"all_terms","q":"Evidence check: FTO in the context of weight loss"},"results":[{"answer":"Evidence for FTO in the context of weight loss is moderate, primarily from GWAS linking FTO variants (e.g., rs9939609) to higher BMI and obesity risk. However, effect sizes are small – risk allele carriers average only about 2–3 kg more body weight. For actual weight loss, findings are mixed: some studies suggest risk carriers benefit more from structured diet or exercise programs, while others show no difference. Clinical relevance for individuals is limited because lifestyle factors (calorie balance, physical activity) dominate genetic influence. An FTO test alone does not provide actionable guidance for weight loss. Evidence is rated 'human-moderate'. Consumers should be aware that such tests are often marketed without robust validation for personalized recommendations.","area":"gesundheit","canonical_id":"gesundheit:canonical-a55fce79c564f9801bdb4737","id":"public-d8262a674defbe972f156b04","kind":"qa","language":"en","publication_status":"existing_native_answer_privacy_screened_sources_pending","question":"Evidence check: FTO in the context of weight loss","score":24.91705705,"snippet":"Evidence for FTO in the context of weight loss is moderate, primarily from GWAS linking FTO variants (e.g., rs9939609) to higher BMI and obesity risk. However, effect sizes are small – risk allele carriers average only about 2–3 kg more body weight. For actual weight loss, findings are mixed: some studies suggest risk carriers benefit more from structured diet or exercise programs, while others show no difference. Clinical relevance for individuals is limited because lifestyle factors (calorie balance, physical activity) dominate genetic influence. An FTO test alone does not provide actionable guidance for weight loss. Evidence is rated 'human-moderate'. Consumers should be aware that such t","sources":[],"title":"Evidence check: FTO in the context of weight loss","url":"https://tikki.wiki/wissen/gesundheit/frage/public-d8262a674defbe972f156b04/evidence-check-fto-in-the-context-of-weight-loss/","verification":{"claim_support_verified":false,"human_reviewed":false,"quote_exact_match":false,"source_identity_verified":false,"tier":"existing_native_answer_privacy_screened_sources_pending"}},{"answer":"The FTO gene is the most robustly replicated obesity locus from genome-wide association studies. Carriers of the risk allele (e.g., rs9939609) have a modestly higher BMI (≈0.3–0.5 kg/m² per allele) and increased obesity risk. However, the effect size is small and explains only a tiny fraction of population weight variance. In weight‑loss interventions, FTO genotype does not reliably predict success: meta-analyses show no significant difference in weight change between risk and non‑risk carriers. The proposed mechanism involves altered appetite regulation (e.g., higher ghrelin, reduced satiety), but evidence is largely observational. Crucially, having the risk allele does not prevent weight loss; lifestyle factors (caloric deficit, physical activity) are far more decisive. Commercial DNA tests often overstate FTO’s impact. For consumers, the take‑home message is that FTO status should not drive major dietary changes. Evidence is strong for association but weak for clinical utility in weight management.","area":"gesundheit","canonical_id":"gesundheit:canonical-c45997fffb827b1c62bf9d0e","id":"public-f7b7f9bacebac3262a04e278","kind":"qa","language":"en","publication_status":"existing_native_answer_privacy_screened_sources_pending","question":"Evidence check: FTO in the context of Abnehmen","score":23.91369588,"snippet":"The FTO gene is the most robustly replicated obesity locus from genome-wide association studies. Carriers of the risk allele (e.g., rs9939609) have a modestly higher BMI (≈0.3–0.5 kg/m² per allele) and increased obesity risk. However, the effect size is small and explains only a tiny fraction of population weight variance. In weight‑loss interventions, FTO genotype does not reliably predict success: meta-analyses show no significant difference in weight change between risk and non‑risk carriers. The proposed mechanism involves altered appetite regulation (e.g., higher ghrelin, reduced satiety), but evidence is largely observational. Crucially, having the risk allele does not prevent weight l","sources":[],"title":"Evidence check: FTO in the context of Abnehmen","url":"https://tikki.wiki/wissen/gesundheit/frage/public-f7b7f9bacebac3262a04e278/evidence-check-fto-in-the-context-of-abnehmen/","verification":{"claim_support_verified":false,"human_reviewed":false,"quote_exact_match":false,"source_identity_verified":false,"tier":"existing_native_answer_privacy_screened_sources_pending"}},{"answer":"The combination of a fertility check with weight loss is often marketed as a 'fertility boost', but the scientific evidence is weak. Weight loss can improve fertility in overweight women (e.g., via better insulin sensitivity, hormone regulation), but a specific 'fertility check' (e.g., DNA test on single genes like FTO, MC4R, or hormone markers) does not provide clinically actionable prediction for individual fertility outcomes from weight loss. Evidence for direct gene effects on fertility in the context of diet is mostly mechanistic or from GWAS with small effect sizes. Hormonal biomarkers (AMH, FSH) are more established but rarely part of consumer tests. Without specific study data from the provided context, the validity remains unclear. Beware of overblown claims: weight loss alone does not guarantee fertility, and genetic tests cannot replace medical fertility workup.","area":"gesundheit","canonical_id":"gesundheit:canonical-2a532c75d4073b4c276f961a","id":"public-86465f0c3d57d06462e7231d","kind":"qa","language":"en","publication_status":"existing_native_answer_privacy_screened_sources_pending","question":"Evidence check: Fertility Check in the context of weight loss","score":23.70749704,"snippet":"The combination of a fertility check with weight loss is often marketed as a 'fertility boost', but the scientific evidence is weak. Weight loss can improve fertility in overweight women (e.g., via better insulin sensitivity, hormone regulation), but a specific 'fertility check' (e.g., DNA test on single genes like FTO, MC4R, or hormone markers) does not provide clinically actionable prediction for individual fertility outcomes from weight loss. Evidence for direct gene effects on fertility in the context of diet is mostly mechanistic or from GWAS with small effect sizes. Hormonal biomarkers (AMH, FSH) are more established but rarely part of consumer tests. Without specific study data from t","sources":[],"title":"Evidence check: Fertility Check in the context of weight loss","url":"https://tikki.wiki/wissen/gesundheit/frage/public-86465f0c3d57d06462e7231d/evidence-check-fertility-check-in-the-context-of-weight-loss/","verification":{"claim_support_verified":false,"human_reviewed":false,"quote_exact_match":false,"source_identity_verified":false,"tier":"existing_native_answer_privacy_screened_sources_pending"}},{"answer":"The question about ADH1B in the context of weight loss lacks direct evidence in the provided knowledge. ADH1B encodes alcohol dehydrogenase, an enzyme involved in ethanol metabolism. Variants such as rs1229984 affect alcohol breakdown and may influence drinking behavior and alcohol dependence risk, but a direct, robust link to weight loss is not established. The context discusses DNA Slim Tests, FTO, MC4R, and TCF7L2, noting that evidence for gene-diet interactions in weight management is generally weak or marketing-driven. No specific studies or data on ADH1B and weight loss are present in the provided sources. Therefore, the evidence grade is 'unclear'. Consumers should be cautious: genetic testing for weight loss often overpromises. Effective weight management relies on lifestyle factors, not single gene variants. Any claim linking ADH1B directly to weight loss is currently unsupported by the available evidence.","area":"gesundheit","canonical_id":"gesundheit:canonical-84524cae2939dba85020a7a4","id":"public-6cc91e1a2c958deb739f58a5","kind":"qa","language":"en","publication_status":"existing_native_answer_privacy_screened_sources_pending","question":"Evidence check: ADH1B in the context of weight loss","score":23.65357828,"snippet":"The question about ADH1B in the context of weight loss lacks direct evidence in the provided knowledge. ADH1B encodes alcohol dehydrogenase, an enzyme involved in ethanol metabolism. Variants such as rs1229984 affect alcohol breakdown and may influence drinking behavior and alcohol dependence risk, but a direct, robust link to weight loss is not established. The context discusses DNA Slim Tests, FTO, MC4R, and TCF7L2, noting that evidence for gene-diet interactions in weight management is generally weak or marketing-driven. No specific studies or data on ADH1B and weight loss are present in the provided sources. Therefore, the evidence grade is 'unclear'. Consumers should be cautious: geneti","sources":[],"title":"Evidence check: ADH1B in the context of weight loss","url":"https://tikki.wiki/wissen/gesundheit/frage/public-6cc91e1a2c958deb739f58a5/evidence-check-adh1b-in-the-context-of-weight-loss/","verification":{"claim_support_verified":false,"human_reviewed":false,"quote_exact_match":false,"source_identity_verified":false,"tier":"existing_native_answer_privacy_screened_sources_pending"}},{"answer":"The evidence for a DNA metabolism test in the context of weight loss is currently **mixed/unclear**. While certain gene variants (e.g., in FTO, TCF7L2, PPARG) have been associated with metabolic traits in GWAS, their effect sizes are small and predictive value for individual weight loss is limited. The provided context does not include specific studies on such a test. Most commercial DNA tests for weight loss rely on mechanistic or population-based associations rather than randomized controlled trials. **Caveats:** Results vary by ancestry; lifestyle factors (diet, exercise) have a much larger impact. A DNA test may offer hints but does not replace evidence-based nutritional counseling. **Safety note:** No direct risks, but unrealistic expectations may lead to frustration or unnecessary supplement purchases.","area":"gesundheit","canonical_id":"gesundheit:canonical-7f6818afeda9556a6121a561","id":"public-e4ebaf6bc5f7195da8c7f2b3","kind":"qa","language":"en","publication_status":"existing_native_answer_privacy_screened_sources_pending","question":"Evidence check: DNA Stoffwechseltest in the context of weight loss","score":23.61601109,"snippet":"The evidence for a DNA metabolism test in the context of weight loss is currently **mixed/unclear**. While certain gene variants (e.g., in FTO, TCF7L2, PPARG) have been associated with metabolic traits in GWAS, their effect sizes are small and predictive value for individual weight loss is limited. The provided context does not include specific studies on such a test. Most commercial DNA tests for weight loss rely on mechanistic or population-based associations rather than randomized controlled trials. **Caveats:** Results vary by ancestry; lifestyle factors (diet, exercise) have a much larger impact. A DNA test may offer hints but does not replace evidence-based nutritional counseling. **Sa","sources":[],"title":"Evidence check: DNA Stoffwechseltest in the context of weight loss","url":"https://tikki.wiki/wissen/gesundheit/frage/public-e4ebaf6bc5f7195da8c7f2b3/evidence-check-dna-stoffwechseltest-in-the-context-of-weight-loss/","verification":{"claim_support_verified":false,"human_reviewed":false,"quote_exact_match":false,"source_identity_verified":false,"tier":"existing_native_answer_privacy_screened_sources_pending"}},{"answer":"The SLIM DNA-Test (or similar weight-loss genetic tests) often claims personalized recommendations based on variants like FTO, MC4R, or VDR. However, the scientific evidence is limited: FTO rs9939609 (A allele) is associated with higher BMI (GWAS p=4e-51), but the effect per allele is only ~0.3 BMI units. A direct impact on sleep quality or chronotype is not established – only an indirect link via sleep apnea in severe obesity. VDR variants affect vitamin D metabolism, and low vitamin D is linked to poorer sleep, but a causal effect on circadian rhythm is lacking. The Mediterranean-fiber diet, in contrast, shows robust human evidence for weight loss, reduced inflammation, and improved microbiome diversity – independent of genotype. Bottom line: A DNA test alone is insufficiently validated for weight loss and sleep. More actionable are biomarkers like HbA1c, hs-CRP, or blood vitamin D levels. Evidence is mixed: mechanistic and observational, but not strong enough for clinical recommendations.","area":"gesundheit","canonical_id":"gesundheit:canonical-82acd24271d458c7aa5edf5f","id":"public-0e07f7d7130aa4895e835326","kind":"qa","language":"en","publication_status":"existing_native_answer_privacy_screened_sources_pending","question":"Evidence check: WeightLoss | SLIM DNA-Test in the context of Schlaf","score":23.60187091,"snippet":"The SLIM DNA-Test (or similar weight-loss genetic tests) often claims personalized recommendations based on variants like FTO, MC4R, or VDR. However, the scientific evidence is limited: FTO rs9939609 (A allele) is associated with higher BMI (GWAS p=4e-51), but the effect per allele is only ~0.3 BMI units. A direct impact on sleep quality or chronotype is not established – only an indirect link via sleep apnea in severe obesity. VDR variants affect vitamin D metabolism, and low vitamin D is linked to poorer sleep, but a causal effect on circadian rhythm is lacking. The Mediterranean-fiber diet, in contrast, shows robust human evidence for weight loss, reduced inflammation, and improved microb","sources":[],"title":"Evidence check: WeightLoss | SLIM DNA-Test in the context of Schlaf","url":"https://tikki.wiki/wissen/gesundheit/frage/public-0e07f7d7130aa4895e835326/evidence-check-weightloss-slim-dna-test-in-the-context-of-schlaf/","verification":{"claim_support_verified":false,"human_reviewed":false,"quote_exact_match":false,"source_identity_verified":false,"tier":"existing_native_answer_privacy_screened_sources_pending"}},{"answer":"The query concerns a 'Hormoncheck Männer' (male hormone check) in the context of weight loss. The provided knowledge context contains no direct information about this specific test. The snippets cover DNA variants (LEPR, MTHFR, CYP1A2, IL-6, SOD2, FTO) and general metabolism analyses, but not a male hormone panel. While hormonal factors like testosterone, cortisol, or thyroid hormones can influence weight management, the evidence for commercial hormone tests as a standalone basis for weight loss is weak. Many such tests are marketed with exaggerated claims without clinical validation. A hormone check may offer supplementary insights but does not replace medical diagnostics if an endocrine disorder is suspected. The given contexts lack any peer-reviewed studies or guidelines on this topic. Therefore, the evidence level is 'unclear' to 'marketing'. Consumers should remain cautious and prioritize evidence-based approaches: dietary changes, physical activity, and professional medical advice for weight loss.","area":"gesundheit","canonical_id":"gesundheit:canonical-4a149659e1f49dc19ca8a3e5","id":"public-77f75db7a97a83316cf6146d","kind":"qa","language":"en","publication_status":"existing_native_answer_privacy_screened_sources_pending","question":"Evidence check: Hormoncheck Männer in the context of weight loss","score":23.59289774,"snippet":"The query concerns a 'Hormoncheck Männer' (male hormone check) in the context of weight loss. The provided knowledge context contains no direct information about this specific test. The snippets cover DNA variants (LEPR, MTHFR, CYP1A2, IL-6, SOD2, FTO) and general metabolism analyses, but not a male hormone panel. While hormonal factors like testosterone, cortisol, or thyroid hormones can influence weight management, the evidence for commercial hormone tests as a standalone basis for weight loss is weak. Many such tests are marketed with exaggerated claims without clinical validation. A hormone check may offer supplementary insights but does not replace medical diagnostics if an endocrine di","sources":[],"title":"Evidence check: Hormoncheck Männer in the context of weight loss","url":"https://tikki.wiki/wissen/gesundheit/frage/public-77f75db7a97a83316cf6146d/evidence-check-hormoncheck-maenner-in-the-context-of-weight-loss/","verification":{"claim_support_verified":false,"human_reviewed":false,"quote_exact_match":false,"source_identity_verified":false,"tier":"existing_native_answer_privacy_screened_sources_pending"}},{"answer":"VKORC1 encodes vitamin K epoxide reductase complex subunit 1, a key enzyme in vitamin K recycling and a primary target of warfarin. There is no credible scientific evidence linking VKORC1 variants to weight loss, metabolic rate, or body composition. Its well-established role is in pharmacogenetics: variants affect warfarin sensitivity and dosing. Any claim that VKORC1 testing aids weight management is not supported by human studies and likely stems from marketing overreach. DNA tests for weight loss should focus on genes with moderate evidence like FTO, MC4R, or PPARG, but even these have limited predictive power. Consumers should be cautious: VKORC1 testing is only clinically indicated for anticoagulant therapy. For weight loss, evidence-based strategies (diet, exercise, behavior) remain far more impactful than single-gene tests.","area":"gesundheit","canonical_id":"gesundheit:canonical-ed200de15d5421c81346f249","id":"public-5f1297470de049a124e42751","kind":"qa","language":"en","publication_status":"existing_native_answer_privacy_screened_sources_pending","question":"Evidence check: VKORC1 in the context of weight loss","score":23.58683281,"snippet":"VKORC1 encodes vitamin K epoxide reductase complex subunit 1, a key enzyme in vitamin K recycling and a primary target of warfarin. There is no credible scientific evidence linking VKORC1 variants to weight loss, metabolic rate, or body composition. Its well-established role is in pharmacogenetics: variants affect warfarin sensitivity and dosing. Any claim that VKORC1 testing aids weight management is not supported by human studies and likely stems from marketing overreach. DNA tests for weight loss should focus on genes with moderate evidence like FTO, MC4R, or PPARG, but even these have limited predictive power. Consumers should be cautious: VKORC1 testing is only clinically indicated for ","sources":[],"title":"Evidence check: VKORC1 in the context of weight loss","url":"https://tikki.wiki/wissen/gesundheit/frage/public-5f1297470de049a124e42751/evidence-check-vkorc1-in-the-context-of-weight-loss/","verification":{"claim_support_verified":false,"human_reviewed":false,"quote_exact_match":false,"source_identity_verified":false,"tier":"existing_native_answer_privacy_screened_sources_pending"}},{"answer":"The NutriCare | INFINITY DNA test is marketed for weight loss, but it relies on nutrigenetic variants (e.g., FTO, PPARGC1A, TCF7L2) with small effect sizes on metabolism and satiety. Evidence for clinically meaningful weight loss prediction is weak: GWAS associations show modest risk changes (e.g., OR 1.5 for TCF7L2 in diabetes), but lifestyle (calorie balance, exercise) overwhelmingly determines outcomes. The test may serve as a motivational tool but does not replace medical advice or evidence-based diet. Caveat: results are predispositive, not diagnostic. A blood test for biomarkers (e.g., HbA1c, insulin) would be more informative. Safety note: No direct risks, but misinterpretation may lead to unnecessary dietary restrictions.","area":"gesundheit","canonical_id":"gesundheit:canonical-90d824597ca0b02b74824620","id":"public-af9cd1505eaf136b137fde34","kind":"qa","language":"en","publication_status":"existing_native_answer_privacy_screened_sources_pending","question":"Evidence check: NutriCare | INFINITY DNA-Test in the context of weight loss","score":23.57188852,"snippet":"The NutriCare | INFINITY DNA test is marketed for weight loss, but it relies on nutrigenetic variants (e.g., FTO, PPARGC1A, TCF7L2) with small effect sizes on metabolism and satiety. Evidence for clinically meaningful weight loss prediction is weak: GWAS associations show modest risk changes (e.g., OR 1.5 for TCF7L2 in diabetes), but lifestyle (calorie balance, exercise) overwhelmingly determines outcomes. The test may serve as a motivational tool but does not replace medical advice or evidence-based diet. Caveat: results are predispositive, not diagnostic. A blood test for biomarkers (e.g., HbA1c, insulin) would be more informative. Safety note: No direct risks, but misinterpretation may le","sources":[],"title":"Evidence check: NutriCare | INFINITY DNA-Test in the context of weight loss","url":"https://tikki.wiki/wissen/gesundheit/frage/public-af9cd1505eaf136b137fde34/evidence-check-nutricare-infinity-dna-test-in-the-context-of-weight-loss/","verification":{"claim_support_verified":false,"human_reviewed":false,"quote_exact_match":false,"source_identity_verified":false,"tier":"existing_native_answer_privacy_screened_sources_pending"}},{"answer":"Evaluating the evidence for a Longevity DNA Test in the context of weight loss requires a nuanced approach. The MyBody-X Longevity test likely examines genes related to aging, metabolism, and inflammation – such as those involved in telomere maintenance, DNA repair, or oxidative stress. However, direct, clinically validated genetic markers for weight loss are lacking. Polygenic risk scores for obesity (e.g., FTO, MC4R) explain only a small fraction of weight variance (typically <5 %). The evidence for using such tests to guide personalized weight loss strategies is currently 'mixed' to 'unclear'. While insights into nutrient metabolism (e.g., vitamin D, folate) or insulin sensitivity may offer some guidance, lifestyle factors – calorie balance, physical activity, sleep – remain paramount. The test does not provide a direct weight loss plan but may serve as a supplementary tool. Safety note: Not a clinical diagnostic; consult a physician for significant weight concerns. Sources: No specific PMIDs provided in the context.","area":"gesundheit","canonical_id":"gesundheit:canonical-70fbba850ac3e527bd0a623e","id":"public-28ec52e29732bcc08eaa4e5a","kind":"qa","language":"en","publication_status":"existing_native_answer_privacy_screened_sources_pending","question":"Evidence check: Longevity DNA Test in the context of weight loss","score":23.50627741,"snippet":"Evaluating the evidence for a Longevity DNA Test in the context of weight loss requires a nuanced approach. The MyBody-X Longevity test likely examines genes related to aging, metabolism, and inflammation – such as those involved in telomere maintenance, DNA repair, or oxidative stress. However, direct, clinically validated genetic markers for weight loss are lacking. Polygenic risk scores for obesity (e.g., FTO, MC4R) explain only a small fraction of weight variance (typically <5 %). The evidence for using such tests to guide personalized weight loss strategies is currently 'mixed' to 'unclear'. While insights into nutrient metabolism (e.g., vitamin D, folate) or insulin sensitivity may off","sources":[],"title":"Evidence check: Longevity DNA Test in the context of weight loss","url":"https://tikki.wiki/wissen/gesundheit/frage/public-28ec52e29732bcc08eaa4e5a/evidence-check-longevity-dna-test-in-the-context-of-weight-loss/","verification":{"claim_support_verified":false,"human_reviewed":false,"quote_exact_match":false,"source_identity_verified":false,"tier":"existing_native_answer_privacy_screened_sources_pending"}}],"schema_version":"tikki.search-response.v1"}